MML Investors Services’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-6,432
Closed -$213K 2130
2022
Q1
$213K Sell
6,432
-518
-7% -$14.4K ﹤0.01% 1927
2021
Q4
$227K Sell
6,950
-800
-10% -$27.2K ﹤0.01% 1855
2021
Q3
$325K Sell
7,750
-24,750
-76% -$891K ﹤0.01% 1599
2021
Q2
$1.26M Sell
32,500
-2,333
-7% -$83.4K 0.01% 903
2021
Q1
$1.19M Sell
34,833
-5,992
-15% -$256K 0.01% 849
2020
Q4
$1.85M Sell
40,825
-2,416
-6% -$84.4K 0.02% 622
2020
Q3
$1.19M Buy
43,241
+4,690
+12% +$153K 0.01% 706
2020
Q2
$1.42M Buy
38,551
+1,471
+4% +$54.8K 0.02% 614
2020
Q1
$1.2M Buy
37,080
+1,194
+3% +$49.7K 0.02% 572
2019
Q4
$1.47M Buy
35,886
+4,244
+13% +$168K 0.02% 578
2019
Q3
$1.13M Buy
31,642
+3,192
+11% +$129K 0.02% 630
2019
Q2
$1.46M Buy
28,450
+16,075
+130% +$803K 0.02% 589
2019
Q1
$709K Buy
+12,375
New +$613K 0.01% 849

Other funds holding RGNX